Antimicrobial Stewardship Audit
Audit antimicrobial prescribing for indication, agent choice, duration, de-escalation, and culture review in one structured pass. Use it to catch unnecessary therapy, missed narrowing opportunities, and weak stewardship documentation.
Trusted by frontline teams 15 years of frontline software AI customization in seconds
Built for: Hospitals · Acute Care Clinics · Long Term Care · Outpatient Infusion Centers
Overview
This Antimicrobial Stewardship Audit template is a structured chart-review tool for evaluating whether an antimicrobial course was started for a valid clinical reason and managed appropriately after initiation. It walks the reviewer through the full stewardship sequence: audit context, clinical indication, agent selection and regimen, duration and stop date, de-escalation and culture review, and documentation of recommendations.
Use it when you need to review individual antibiotic cases for appropriateness, especially when broad-spectrum therapy, prolonged courses, culture-driven narrowing, or IV-to-PO conversion decisions matter. It is useful for routine stewardship rounds, targeted audits on restricted agents, unit-level quality review, and follow-up after a positive culture or a negative culture that should have prompted reassessment.
Do not use it as a generic medication reconciliation form or as a substitute for bedside clinical judgment. If the case is purely prophylactic, noninfectious, or outside antimicrobial decision-making, a different review tool may fit better. The template is also not meant to replace local infectious disease guidance, antibiograms, or facility policy; it is the audit record that shows whether those standards were followed.
The strongest use of this template is consistency. It helps reviewers identify deficiencies such as missing indications, overly broad therapy, absent stop dates, failure to narrow after susceptibilities, and incomplete stewardship communication. That makes it easier to close the loop with prescribers and to trend recurring non-conformance across services or units.
Standards & compliance context
- This template supports antimicrobial stewardship documentation practices commonly expected in healthcare quality programs and accreditation reviews.
- It aligns with public health and professional stewardship guidance that emphasizes indication review, culture-directed therapy, de-escalation, and duration control.
- Where your facility has local infectious disease protocols, antibiograms, or restricted-antibiotic policies, this audit should verify adherence to those controls.
- The template can be adapted to outpatient, inpatient, or long-term care workflows without changing the core stewardship review logic.
General regulatory context for orientation only — verify current requirements with counsel or the relevant agency before relying on this template for compliance.
What's inside this template
Audit Context
This section matters because it anchors the case, reviewer, and review type so the audit can be traced and trended later.
-
Patient or case identifier recorded
Record the chart number, encounter ID, or audit case reference used for this review.
-
Antimicrobial regimen reviewed
Document the antimicrobial agent(s), dose, route, and frequency being audited.
-
Review date and reviewer documented
Enter the date/time of the stewardship review and the reviewer name or role.
-
Review type identified
Select the audit context for this review.
Clinical Indication
This section matters because stewardship starts with proving there was a valid infectious indication and not just a reflex prescription.
-
Documented indication present
A specific infection or prophylaxis indication is documented in the chart or order.
-
Indication is clinically appropriate
The documented indication is supported by signs, symptoms, labs, imaging, or procedural context.
-
Therapy is treatment rather than unnecessary prophylaxis
Confirm the antimicrobial is justified as treatment, targeted prophylaxis, or guideline-supported prophylaxis.
-
Source of infection identified when applicable
If relevant, the suspected or confirmed source is documented (for example: urinary, respiratory, skin/soft tissue, intra-abdominal, bloodstream).
Agent Selection and Regimen
This section matters because the chosen drug, dose, route, and spectrum should match the likely or confirmed pathogen without unnecessary excess.
-
Agent selection aligns with likely or confirmed pathogen
The chosen antimicrobial is appropriate for the suspected organism(s), infection site, and local guidance.
-
Spectrum is as narrow as clinically appropriate
Broad-spectrum therapy is avoided when a narrower agent would provide adequate coverage.
-
Dose, route, and frequency are appropriate
The regimen matches patient factors such as renal/hepatic function, weight, severity of illness, and site of infection.
-
Allergy or intolerance considerations addressed
Documented allergies, prior adverse reactions, and intolerance history were considered in agent selection.
-
Therapeutic duplication absent
No unnecessary duplicate antimicrobial coverage is present unless specifically justified.
Duration and Stop Date
This section matters because even appropriate antibiotics become a problem when duration is unclear or not reassessed on time.
-
Planned duration or stop date documented
A clear stop date, planned duration, or review date is documented in the order or progress note.
-
Duration is consistent with guideline or indication
The planned duration is consistent with the infection type, source control status, and clinical response.
-
IV-to-PO conversion considered when clinically appropriate
Oral step-down was considered when the patient was hemodynamically stable, improving, and able to absorb oral therapy.
-
Therapy reassessment documented within expected timeframe
The regimen was reassessed at an appropriate interval for ongoing need and duration adjustment.
De-escalation and Culture Review
This section matters because culture data should drive narrowing, stopping, or changing therapy when the results support it.
-
Cultures obtained before antibiotics when clinically indicated
Appropriate cultures or diagnostic specimens were collected before antimicrobial initiation when feasible and indicated.
-
Culture and susceptibility results reviewed
Available microbiology results were reviewed and documented in the stewardship assessment.
-
Therapy de-escalated when results supported narrowing
Broad therapy was narrowed, stopped, or adjusted based on culture, susceptibility, or clinical data when appropriate.
-
Negative or contaminant cultures prompted reassessment
If cultures were negative or suggested contamination, the need for continued therapy was reassessed and documented.
Documentation and Stewardship Notes
This section matters because a recommendation only improves care if it is clearly documented, communicated, and followed up.
-
Stewardship recommendation documented
Document any recommendation to continue, stop, narrow, switch to oral therapy, or obtain additional diagnostics.
-
Recommendation communicated to care team
Confirm the recommendation was communicated to the responsible clinician, pharmacist, or team.
-
Follow-up plan documented
Record any required follow-up, such as repeat review date, lab monitoring, or culture follow-up.
How to use this template
- 1. Open the case chart and record the patient or case identifier, review date, reviewer name, and whether the review is prospective, concurrent, or retrospective.
- 2. Confirm the documented indication, infection source, and whether the antimicrobial is being used for treatment rather than unnecessary prophylaxis.
- 3. Review the agent, dose, route, frequency, allergy history, and duplication risk against the likely or confirmed pathogen and local guidance.
- 4. Check whether a planned duration or stop date is documented and whether IV-to-PO conversion or earlier discontinuation should have been considered.
- 5. Compare culture and susceptibility results with the current regimen, document any de-escalation opportunity, and note whether negative or contaminant cultures changed the plan.
- 6. Record the stewardship recommendation, communicate it to the care team, and document the follow-up plan or unresolved issue.
Best practices
- Document the exact infection syndrome or source whenever it is known, because vague indications make later review and trend analysis unreliable.
- Treat missing stop dates as a stewardship deficiency, not a clerical issue, because open-ended therapy often becomes prolonged therapy.
- Review cultures before the first dose when clinically indicated, but also reassess again when results return so narrowing is not missed.
- Flag duplicate coverage, redundant anaerobic therapy, or overlapping gram-negative agents as therapeutic duplication when there is no clear clinical reason.
- Check allergy entries for reaction type and severity before accepting them as a reason to avoid first-line therapy or to choose a broader agent.
- Use the local antibiogram or facility guideline to judge whether the selected agent is narrower than necessary for the suspected source and organism.
- Capture the stewardship recommendation in language the prescriber can act on, such as stop, narrow, switch to oral, or reassess in 48 to 72 hours.
What this template typically catches
Issues teams running this template most often surface in practice:
Common use cases
Frequently asked questions
What does this antimicrobial stewardship audit template cover?
It covers the core review points that determine whether an antibiotic order is justified and appropriately managed: indication, agent selection, dose and route, duration, culture review, de-escalation, and follow-up documentation. It is designed for case-by-case review of individual antimicrobial courses, not for inventory control or pharmacy stock audits. The template helps reviewers record both clinical appropriateness and stewardship actions in one place.
Who should use this template?
It is typically used by antimicrobial stewardship pharmacists, infectious disease clinicians, quality teams, and designated prescribers reviewing antibiotic use. In smaller facilities, a nurse leader, pharmacist, or medical director may complete it as part of chart review. The key is that the reviewer has access to the chart, culture data, and local prescribing guidance.
How often should antimicrobial stewardship audits be performed?
Use it on a recurring cadence that matches your program goals, such as weekly, monthly, or during targeted review periods for high-risk units. It also works well for focused audits after a formulary change, resistance trend, or stewardship intervention. The template is flexible enough for both routine surveillance and one-off case review.
When should this audit be used instead of a general medication review?
Use it when the main question is whether an antimicrobial course is clinically justified and aligned with stewardship principles. It is more specific than a general medication review because it checks source, culture results, narrowing opportunities, and stop dates. If you only need to confirm administration timing or basic med reconciliation, a different template is a better fit.
Does this template align with regulatory or accreditation expectations?
Yes, it supports the documentation and review practices expected in antimicrobial stewardship programs under healthcare quality frameworks and accreditation expectations. It also aligns with common stewardship principles promoted by public health and professional guidance, including culture-directed therapy, reassessment, and de-escalation. It is not a legal form, but it helps create a defensible audit trail.
What are the most common mistakes this audit catches?
Common findings include missing indications, overly broad empiric therapy that is never narrowed, and stop dates that are absent or inconsistent with the diagnosis. It also catches duplicate therapy, missed IV-to-PO conversion opportunities, and cases where negative or contaminant cultures were not reassessed. Those issues are often easy to miss without a structured review.
Can this template be customized for different units or infection types?
Yes. You can tailor the review to ICU, emergency department, surgical prophylaxis, pneumonia, urinary tract infection, skin and soft tissue infection, or other service lines. Many teams also add local antibiogram references, restricted agents, or unit-specific stewardship notes to match their workflow.
How does this compare with ad hoc chart review?
Ad hoc review tends to be inconsistent: one reviewer may focus on cultures while another focuses on duration, which makes trend analysis difficult. This template standardizes the same decision points across cases so you can compare findings, track recurring deficiencies, and document interventions consistently. It also makes follow-up easier because the review fields are already organized.
Related templates
Go deeper on the topic
-
A daily huddle is a brief (10–15 minute) standing meeting held at the start of a shift or workday to align the team on priorities, surface issues, and...
-
A deskless worker is any employee whose job happens without a desk, a company laptop, or a fixed workstation. They're roughly 80% of the global workforce —...
-
A frontline employee app is a phone-first application that gives hourly, field, and deskless workers access to their schedule, pay, announcements, training,...
-
A frontline worker is any employee whose job happens away from a desk — on a production floor, in a patient room, behind a store counter, in a customer's...
-
Learn how to run a successful business with remote employees using proven strategies to boost autonomy, productivity, and engagement.
-
Empower frontline workers with a SuperApp that unifies mobile access, communication, and engagement to boost productivity and retention.
-
Reaching everyone isn't enough. Learn why broadcast approval workflows and content moderation are essential for trustworthy internal communications.
-
Build lasting partner and vendor relationships with 5 proven strategies to improve communication, trust, and long-term business success.
Ready to use this template?
Get started with MangoApps and use Antimicrobial Stewardship Audit with your team — pricing built for small business.
